The Conference for Retroviruses and Opportunistic Infections 2025 opened with a session dedicated to informing attendees ...

Immunocore’s big swing for a functional HIV cure has cleared its first hurdle. | Immunocore’s big swing for a functional HIV ...

This research on a T-cell–targeting vaccines in HIV has implications for future study design to incorporate consideration of age and years on antiretroviral therapy (ART) to evaluate the level of ...

| Real-world evidence lets us see how HIV medicines work in real life, helping HCPs provide better care and improving ...

LEN is a first-in-class, long-acting HIV-1 capsid inhibitor that disrupts multiple stages of the viral replication cycle. By ...

North America was the major shareholder in 2022. However, Asia-Pacific is expected to witness the highest CAGR during the forecast period. PO ...

By Albert Allotey Accra, GNA-The JANOK Foundation, a non-governmental organization at Laterbiokorshie in Accra has ...

HIV-positive mothers with undetectable viral load can now safely breastfeed their infants, according to recently updated ...

The Association of Government Information Officers in Region 8 (AGIO-8), led by its president, lawyer Jonalyndie B. Chua ...

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study by researchers ...

Researchers from the Max Planck Institute of Biochemistry have discovered the mechanism behind an important step in the life ...